OUTPATENT VASODILATOR ASSESSMENT USING ILOPROST IN PULMONARY HYPERTENSION (The OVATION Study)
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Iloprost (Primary) ; Nitric oxide
- Indications Pulmonary hypertension
- Focus Diagnostic use
- Acronyms OVATION
- 13 Dec 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 13 Dec 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 21 Jul 2017 Status changed from not yet recruiting to recruiting.